Co-delivery of plasmid-encoded cytokines modulates the immune response to a DNA vaccine delivered by in vivo electroporation

Vaccine

Volumn 25, Issue 14, 2007, Pages 2575-2582

  Yen, Hung Hsun ^a   Scheerlinck, Jean Pierre Y ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cytokines; DNA vaccination; In vivo electroporation; Ovine

Indexed keywords

DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 10; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1ALPHA; NPA PROTEIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG POTENTIATION; ELECTROPORATION; FEMALE; GENE; HAEMONCHUS CONTORTUS; IMMUNE RESPONSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; SHEEP; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, BACTERIAL; ELECTROPORATION; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HAEMOPHILUS VACCINES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; PLASMIDS; SHEEP; T-LYMPHOCYTES; VACCINES, DNA;

EID: 33947190422     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.12.025     Document Type: Article

References (47)

1. Nielsen H.V., Lauemoller S.L., Christiansen L., Buus S., Fomsgaard A., and Petersen E. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun 67 12 (1999) 6358-6363
2. Wu C.J., Huang H.W., and Tao M.H. Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine. Vaccine 21 25-26 (2003) 3938-3945
3. Scheerlinck J.Y. Genetic adjuvants for DNA vaccines. Vaccine 19 17-19 (2001) 2647-2656
4. Kim J.J., Trivedi N.N., Nottingham L.K., Morrison L., Tsai A., Hu Y., et al. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur J Immunol 28 3 (1998) 1089-1103
5. Gurunathan S., Klinman D.M., and Seder R.A. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 18 (2000) 927-974
6. Toka F.N., Pack C.D., and Rouse B.T. Molecular adjuvants for mucosal immunity. Immunol Rev 199 (2004) 100-112
7. Scheerlinck J.P., Casey G., McWaters P., Kelly J., Woollard D., Lightowlers M.W., et al. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. Vaccine 19 28-29 (2001) 4053-4060
8. Aihara H., and Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16 9 (1998) 867-870
9. Mir L.M., Bureau M.F., Gehl J., Rangara R., Rouy D., Caillaud J.M., et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 96 8 (1999) 4262-4267
10. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 6 4 (1999) 508-514
11. Scheerlinck J.P., Karlis J., Tjelle T.E., Presidente P.J., Mathiesen I., and Newton S.E. In vivo electroporation improves immune responses to DNA vaccination in sheep. Vaccine 22 13-14 (2004) 1820-1825
12. Wu C.J., Lee S.C., Huang H.W., and Tao M.H. In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine. Vaccine 22 11-12 (2004) 1457-1464
13. Chaplin P.J., Casey G., De Rose R., Buchan G., Wood P.R., and Scheerlinck J.P. The expression and biologic effects of ovine interleukin-4 on T and B cell proliferation. J Interferon Cytokine Res 20 4 (2000) 419-425
14. Martin H.M., Nash A.D., and Andrews A.E. Cloning and characterisation of an ovine interleukin-10-encoding cDNA. Gene 159 2 (1995) 187-191
15. McInnes C.J., and Haig D.M. Cloning and expression of a cDNA encoding ovine granulocyte-macrophage colony-stimulating factor. Gene 105 2 (1991) 275-279
16. O'Brien P.M., Seow H.F., Entrican G., Coupar B.E., and Wood P.R. Production and characterisation of ovine GM-CSF expressed in mammalian and bacterial cells. Vet Immunol Immunopathol 48 3-4 (1995) 287-298
17. Dunphy J., Horvath A., Barcham G., Balic A., Bischof R., and Meeusen E. Isolation, characterisation and expression of mRNAs encoding the ovine CC chemokines, monocyte chemoattractant protein (MCP)-1alpha and-2. Vet Immunol Immunopathol 82 3-4 (2001) 153-164
18. Montgomery D.C. Design and analysis of experiments. 4th ed. (1996), John Wiley & Sons Inc., New York p. 63-149
19. Kennedy N.J., Spithill T.W., Tennent J., Wood P.R., and Piedrafita D. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy. Vaccine 24 7 (2006) 970-979
20. Barry M.A., and Johnston S.A. Biological features of genetic immunization. Vaccine 15 8 (1997) 788-791
21. + dendritic cells. Proc Natl Acad Sci USA 93 6 (1996) 2588-2592
22. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179 4 (1994) 1109-1118
23. Chapuis F., Rosenzwajg M., Yagello M., Ekman M., Biberfeld P., and Gluckman J.C. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 27 2 (1997) 431-441
24. Haddad D., Ramprakash J., Sedegah M., Charoenvit Y., Baumgartner R., Kumar S., et al. Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles. J Immunol 165 7 (2000) 3772-3781
25. Barouch D.H., McKay P.F., Sumida S.M., Santra S., Jackson S.S., Gorgone D.A., et al. Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines. J Virol 77 16 (2003) 8729-8735
26. + T lymphocyte responses. Eur J Immunol 34 4 (2004) 1011-1020
27. Ou-Yang P., Hwang L.H., Tao M.H., Chiang B.L., and Chen D.S. Co-delivery of GM-CSF gene enhances the immune responses of hepatitis C viral core protein-expressing DNA vaccine: role of dendritic cells. J Med Virol 66 3 (2002) 320-328
28. Sin J.I., Kim J.J., Ugen K.E., Ciccarelli R.B., Higgins T.J., and Weiner D.B. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes. Eur J Immunol 28 11 (1998) 3530-3540
29. Chow Y.H., Chiang B.L., Lee Y.L., Chi W.K., Lin W.C., Chen Y.T., et al. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol 160 3 (1998) 1320-1329
30. Kusakabe K., Xin K.Q., Katoh H., Sumino K., Hagiwara E., Kawamoto S., et al. The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine. J immunol 164 6 (2000) 3102-3111
31. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20 (2002) 709-760
32. Mutwiri G., Pontarollo R., Babiuk S., Griebel P., van Drunen Littel-van den Hurk S., Mena A., et al. Biological activity of immunostimulatory CpG DNA motifs in domestic animals. Vet Immunol Immunopathol 91 2 (2003) 89-103
33. Klinman D.M., Currie D., Gursel I., and Verthelyi D. Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol Rev 199 (2004) 201-216
34. Kim J.J., Simbiri K.A., Sin J.I., Dang K., Oh J., Dentchev T., et al. Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV. J Interferon Cytokine Res 19 1 (1999) 77-84
35. Lewis P.J., Cox G.J., van Drunen Littel-van den Hurk S., and Babiuk L.A. Polynucleotide vaccines in animals: enhancing and modulating responses. Vaccine 15 8 (1997) 861-864
36. Sin J.I., Kim J.J., Boyer J.D., Ciccarelli R.B., Higgins T.J., and Weiner D.B. In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model. J Virol 73 1 (1999) 501-509
37. Chun S., Daheshia M., Lee S., and Rouse B.T. Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: implication for gene therapy. Cell Immunol 194 2 (1999) 194-204
38. Manickan E., Daheshia M., Kuklin N., Chun S., and Rouse B.T. Modulation of virus-induced delayed-type hypersensitivity by plasmid DNA encoding the cytokine interleukin-10. Immunology 94 2 (1998) 129-134
39. Evans R., Kamdar S.J., and Duffy T.M. Tumor-derived products induce Il-1 a, Il-1 b, Tnf a, and Il-6 gene expression in murine macrophages: distinctions between tumor- and bacterial endotoxin-induced gene expression. J Leukoc Biol 49 5 (1991) 474-482
40. Yao H.W., Li J., Chen J.Q., and Xu S.Y. A 771726, the active metabolite of leflunomide, inhibits TNF-alpha and IL-1 from Kupffer cells. Inflammation 28 2 (2004) 97-103
41. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
42. Taylor A., Verhagen J., Blaser K., Akdis M., and Akdis C.A. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology 117 4 (2006) 433-442
43. Mills K.H., and Regulatory. T cells: friend or foe in immunity to infection?. Nat Rev Immunol 4 11 (2004) 841-855
44. Hawrylowicz C.M., and O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 5 4 (2005) 271-283
45. Steinbrink K., Wolfl M., Jonuleit H., Knop J., and Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159 10 (1997) 4772-4780
46. Akdis C.A., Joss A., Akdis M., Faith A., and Blaser K. A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J 14 12 (2000) 1666-1668
47. Lombry C., Marteleur A., Arras M., Lison D., Louahed J., Renauld J.C., et al. Local and systemic immune responses to intratracheal instillation of antigen and DNA vaccines in mice. Pharm Res 21 1 (2004) 127-135